New Delhi: The HIV drug Viread will now be available in powder form for HIV positive children after its approval by the US Food and Drug Administration (FDA), a bio-pharmaceutical company said Sunday. The move is expected to benefit millions of HIV positive children."There remains an unmet need for heat-stable, taste-neutral pediatric formulations that do not require cold storage, particularly in resource-limited settings, where mother-to-child transmission remains a significant challenge," Norbert Bischofberger, executive vice president, research and development and chief scientific officer at Gilead Sciences, said in a statement."We are very pleased to provide an important new therapeutic option for younger HIV patients, and will work to make the pediatric formulations of Viread available as quickly as possible," Bischofberger added.
FM Arun Jaitley presents budget in Parliament
What common people want from Modi govt budget
The history of Indian Budget
Marrow Donor Registry of India launches Gujarat chapter